| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/09/1996 | CA1337899C Multi-layer granule |
| 01/09/1996 | CA1337898C High integrity liposomes and method of preparation and use |
| 01/09/1996 | CA1337897C Medicated cleansing pads |
| 01/04/1996 | WO1996000389A1 Method of determining the amount of active substance released from solid or semi-solid preparations administered to humans or animals |
| 01/04/1996 | WO1996000295A1 Targeted gene delivery system |
| 01/04/1996 | WO1996000081A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 01/04/1996 | WO1996000077A1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 01/04/1996 | WO1996000074A1 Pharmaceutical compositions comprising vitamin-d analogs |
| 01/04/1996 | WO1996000072A1 Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
| 01/04/1996 | WO1996000071A1 Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine |
| 01/04/1996 | WO1996000070A1 Treatment of nicotine craving and/or smoking withdrawal symptoms with an oral composition containing nicotine and caffeine or xanthine |
| 01/04/1996 | WO1996000069A1 Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration |
| 01/04/1996 | WO1996000066A1 Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 01/04/1996 | WO1996000065A1 Tacrine pharmaceutical compositions |
| 01/04/1996 | WO1996000060A1 Topical compositions comprising n-acetyl-l-cysteine |
| 01/04/1996 | WO1996000058A1 Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| 01/04/1996 | WO1996000057A1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 01/04/1996 | WO1996000056A1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
| 01/04/1996 | WO1996000055A1 Intraocular irrigating solution containing agent for controlling iop |
| 01/04/1996 | WO1996000047A1 Subcutaneous implant |
| 01/04/1996 | WO1996000016A1 Novel dietetic phospholipid compositions and use thereof as a dietary supplement |
| 01/04/1996 | WO1995033467A3 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
| 01/04/1996 | DE4434929A1 Adhesive anti-inflammatory nystatin ointment |
| 01/04/1996 | DE4423078A1 Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung Carbamazepine sustained release dosage form |
| 01/04/1996 | CA2193954A1 Targeted gene delivery system |
| 01/04/1996 | CA2192821A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 01/04/1996 | CA2192318A1 Intraocular irrigating solution containing agent for controlling iop |
| 01/04/1996 | CA2187332A1 Tacrine pharmaceutical compositions |
| 01/03/1996 | EP0690131A1 Non-reducing saccharide and its production and use |
| 01/03/1996 | EP0689867A1 Process for obtaining raw materials in granular form, raw material in granular form and their use in cosmetics, haircare, veterinary or pharmaceutical fields |
| 01/03/1996 | EP0689843A1 Composition containing soluble thrombomodulins |
| 01/03/1996 | EP0689841A1 Powder preparation for healing damaged skin |
| 01/03/1996 | EP0689840A1 New pharmaceutical composition containing erythromycin base |
| 01/03/1996 | EP0689838A1 Use of diadenosine 5', 5'''- p1, p4 - tetraphosphate for curing ischemic anyocardial disease |
| 01/03/1996 | EP0689834A2 Sustained release food or feed supplement containing vitamins and minerals |
| 01/03/1996 | EP0689833A2 Process for preparing natural actives containing spheroids, especially of vegetable origin, and spheroids thus obtained |
| 01/03/1996 | EP0689832A2 Antibiotic preparation for aural application |
| 01/03/1996 | EP0689461A1 Improvements in or relating to contrast agents |
| 01/03/1996 | EP0689458A1 Active-substance patch for releasing estradiol to the skin |
| 01/03/1996 | EP0689457A1 Stabilised pharmaceutical compositions and methods for preparing same |
| 01/03/1996 | EP0689452A1 Composition for oral administration of peptides |
| 01/03/1996 | EP0689445A1 Aluminium containing pharmaceutical preparation with controlled release |
| 01/03/1996 | EP0689444A1 Tylosin containing sustained release veterinary compositions |
| 01/03/1996 | EP0689442A1 Nasal pharmaceutical composition containing a progestational agent |
| 01/03/1996 | EP0689441A1 Pharmaceutical composition in the form of a kit |
| 01/03/1996 | EP0689438A1 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/03/1996 | EP0689434A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 01/03/1996 | EP0689432A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0689429A1 Cross-linked amylose as a binder/disintegrant in tablets |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0689427A1 Water dispersible therapeutic compounds |
| 01/03/1996 | EP0689426A1 Therapeutic agent for the treatment of melanomas |
| 01/03/1996 | EP0689424A1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| 01/03/1996 | EP0689422A1 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 01/03/1996 | EP0689421A1 Reduced and controlled surface binding of biologically active molecules |
| 01/03/1996 | EP0689419A1 Cosmetic or topical use of an aqueous dispersion based on non-volatile organopolysiloxanes and an acrylamide or homopolymeric copolymer type cross-linked methacryloyloxyethyl trimethylammonium chloride polymer |
| 01/03/1996 | EP0689415A1 Low-viscosity cosmetic and pharmaceutical emulsions |
| 01/03/1996 | EP0689405A1 Methods for protecting tissues and organs from ischemic damage |
| 01/03/1996 | EP0587790B1 Non-chlorofluorocarbon aerosol formulations |
| 01/03/1996 | EP0525132B1 Binding of recognizing substances to liposomes |
| 01/03/1996 | EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
| 01/03/1996 | CN1114220A Compounding of Chinese drugs for curing congenital heart disease |
| 01/03/1996 | CN1114208A Yatongyiwenling-medicine for curing toothache |
| 01/03/1996 | CN1114206A Plaster for curing dysmenorrhea |
| 01/03/1996 | CN1114190A Mixed treating liquid of high molecular synthetic material for double-fold eyelid operation |
| 01/03/1996 | CN1114189A Erythromycin capsule for silkworm |
| 01/03/1996 | CN1114188A Solid pharmacuetical dosage form containing flavored film coating |
| 01/03/1996 | CN1030611C Method for preparing a novel stable form II diritromycin |
| 01/03/1996 | CN1030598C Method for making antidiarrheal towel of baby |
| 01/02/1996 | US5480914 Applying to eye a compoumd incorporating homogeneous dispersion of suspending aid in a fluorinated liquid carrier |
| 01/02/1996 | US5480868 Sustained-release preparation |
| 01/02/1996 | US5480656 Prolonged release microcapsules |
| 01/02/1996 | US5480655 Process for preparing noncohesive coating layer |
| 01/02/1996 | US5480654 Prolonged release dosage form of drug and method for producing the same |
| 01/02/1996 | US5480653 Formulations for sustained release dressings and their use |
| 01/02/1996 | US5480652 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation |
| 01/02/1996 | US5480650 Programmed release tablets containing naproxen |
| 01/02/1996 | US5480649 Procaterol-containing preparation for application to the skin |
| 01/02/1996 | US5480648 Transdermal prostaglandin composition |
| 01/02/1996 | US5480647 Far-infrared radiating medical compound and an adhesive surgical tape layering the compound |
| 01/02/1996 | US5480646 Pad for applying medicaments |
| 01/02/1996 | US5480479 Smooth coating for tablets, adding water by atomizing |
| 01/02/1996 | CA2153083A1 Pharmaceutical compositions and a process for the preparation thereof |
| 01/02/1996 | CA2152684A1 Aerosol delivery of midazolam |
| 01/02/1996 | CA2032904C Blocking agents of edrf effect or formation for the treatment of shock |
| 12/29/1995 | CA2126884A1 Device to alleviate the symptoms of inflammatory diseases |
| 12/28/1995 | WO1995035351A1 Improved long acting gi and esophageal protectant |
| 12/28/1995 | WO1995035301A1 Cationic amphiphiles |
| 12/28/1995 | WO1995035131A1 Controlled release device and method |
| 12/28/1995 | WO1995035112A2 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 12/28/1995 | WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 12/28/1995 | WO1995035104A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 12/28/1995 | WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 12/28/1995 | WO1995035101A1 Nanoparticles stabilized and filterable in sterile conditions |
| 12/28/1995 | WO1995035100A1 Colonic drug delivery composition |
| 12/28/1995 | WO1995035099A1 Vitamin/nutrient dosage regimentation |
| 12/28/1995 | WO1995035097A1 Polymer microparticles for drug delivery |
| 12/28/1995 | WO1995035096A1 Controlled release aqueous emulsion |
| 12/28/1995 | WO1995035095A1 Compositions for applying active substances to or through the skin |